Trial intelligence / Profile preview

Predictors of Antidepressant Response

NCT02178696Phase 4Completed

Sponsor
University of Michigan
Start
Jan 2011
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of citalopram in major depressive disorder (MDD), sponsored by University of Michigan. Started Jan 2011; status: completed.

02

Drugs

citalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT02178696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02178696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call